11:06am ET
Investing
Coronavirus Stocks See Rising Tide in Short Interest
The February 28 short interest data have been compared with the previous figures, and short interest in most of these selected coronavirus stocks increased.
MRNA Coverage Page 12
9:10am ET
Investing
Top Analyst Upgrades and Downgrades: Abbott Labs, Alexion, Avis Budget, DexCom, J&J, Marvell, Moderna, Snap, Splunk, Zoom Video and More
Thursday's top analyst upgrades, downgrades and initiations included Abbott Laboratories, Alexion Pharmaceuticals, Avis Budget, DexCom, Johnson & Johnson, Marvell Technology, Moderna, Snap, Splunk and Zoom Video Communications.
3:38pm ET
Economy
How the Coronavirus Will Harm GDP and Businesses in 2020
With more than 60,000 reported cases of the coronavirus and nearly 1,400 deaths worldwide along with quarantines and travel restrictions, the impact of the disease on global GDP is just beginning to…
4:35pm ET
Health and Healthcare
Moderna Commits to $500 Million Capital Raise, With More Possible
Moderna Inc. (NASDAQ: MRNA) had been the biggest biotech initial public offering ever. The company was quite unlucky in the timing for its IPO, but it managed to get back into favor…
Jon C. Ogg 10:05am ET
Health and Healthcare
12 Stocks Surging That Could Help Treat or Fight Coronavirus
As with almost all pandemic scares and other national and global issues, some speculative stocks manage to see their shares rise sharply.
11:25am ET
Investing
As Coronavirus Spreads, Sensitive China, US, Global Economies Face Great Risks
The Wuhan Coronavirus has escaped China, with the number of cases and the death toll rising. The economic impact beyond the loss of life and suffering is real in many stocks, sectors…
2:35pm ET
Investing
Beyond Rising Deaths, Wuhan Coronavirus Already Hits China, US, Global Economies
The Wuhan Coronavirus has already left China and hit neighboring countries, the U.S. and even in Europe in Australia. As the death toll and number of infected are rising each hour, the…